4 studies found for:    conatumumab
Show Display Options
Rank Status Study
1 Recruiting Open Label Extension Study of Conatumumab and AMG 479
Conditions: Advanced Solid Tumors;   Carcinoid;   Colorectal Cancer;   Locally Advanced;   Lymphoma;   Metastatic Cancer;   Non-Small Cell Lung Cancer;   Sarcoma;   Solid Tumors
Interventions: Drug: FOLFOX6;   Biological: Conatumumab;   Biological: Ganitumab;   Biological: Bevacizumab
2 Withdrawn Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: conatumumab;   Drug: capecitabine;   Drug: gemcitabine hydrochloride;   Radiation: 3-dimensional conformal radiation therapy
3 Recruiting Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Conditions: Relapsed Epithelial Ovarian Cancer;   Relapsed Primary Peritoneal Cancer;   Relapsed Fallopian Tube Cancer
Interventions: Drug: Birinapant;   Drug: Conatumumab
4 Completed
Has Results
Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Metastatic Colorectal Cancer;   Oncology
Interventions: Drug: Panitumumab;   Drug: Conatumumab

Indicates status has not been verified in more than two years